SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?


To: Glenn Petersen who wrote (2761)3/29/2011 12:29:35 PM
From: richardred1 Recommendation  Read Replies (1) | Respond to of 7242
 
Many times business planning strategy has a way of repeating itself.

<sigh>If only Eastman Kodak had kept Eastman Chemical and Sterling Drug.



To: Glenn Petersen who wrote (2761)8/19/2011 11:32:18 AM
From: richardred  Read Replies (1) | Respond to of 7242
 
Looks like LEO APOTHEKER is the newest member of the Starburst Gang. Today it's sure leaving a sour taste to HPQ shareholders. He's starting to remind me what George Fisher did to Kodak.

Hewlett-Packard sums up worst of Corporate America Commentary: Bloated company lacks leadership, innovation, smarts By Jeff Reeves

ROCKVILLE, Md. (MarketWatch) — The market had quite an ugly day on Thursday. But for a brief moment, Hewlett-Packard swam dramatically against the down-current on news it was considering a massive $10 billion buyout of software firm Autonomy, among a host of other reports swirling around the stock that day. HP stock gapped up about 6% at lunch time yesterday even as the Dow Jones bounced along about 400 points below the index’s reading at the opening bell.


Of course, the gains were fleeting and HP (NYSE:HPQ) finished the day down, along with nearly every other stock on Wall Street. Some investors were fooled for about an hour — and then the profits evaporated. Read our story on Friday‘s stock market movements.

Thursday’s performance is a fitting example of how short-lived any rays of hope are for HP these days amid the frenetic pace of company developments. The 10-figure buyouts. The claims that it is rethinking its role in the tech sector. The blatant flaunting of its massive cash stockpile at a time when companies claim to be suffering from the economic downturn.

Hewlett-Packard is everything that’s wrong with corporate America right now — stupidity, a lack of innovation, bloated operations and no leadership.

Stupidity Lots of people thought that Hewlett-Packard was batty when it bought Palm in 2010. At the time, the company didn’t bother to hedge its bets but instead engaged in the typical hyperbole of a big-name buyout. Check out this gem from the official press release on HP.com:



Click to Play
Hewlett-Packard cuts sales outlook Hewlett-Packard stunned the industry by cutting sales outlook, dumping its webOS operations and saying it's considering spinning off PC manufacturing as it reported quarterly results ahead of schedule. Dan Gallagher has details on The News Hub.


“Palm’s innovative operating system provides an ideal platform to expand HP’s mobility strategy and create a unique HP experience spanning multiple mobile connected devices,” said Todd Bradley, an executive vice president in the personal systems group.

Oh yeah? Well what about the news Thursday that Hewlett-Packard will be abandoning any effort to capitalize on the mobile market by killing its tablet computer and mobile phone business based on webOS – the very gadgets Palm was supposed to inspire?

Only can a bloated corporation like HP make a $1.2 billion purchase during a recession and then give up on that buy a mere 16 months later.

Read how a GOP president would avoid recession on InvestorPlace.com.

The icing on the cake: Just this past February, HP made a big to-do about its plan to duke it out with the iPad — and just months after smack-talking, had to eat its words.

Lack of innovation Unfortunately, the $1.2 billion for Palm is just part of a spending spree fueled by HP executives with too much money and a desire to spend it without thinking.

In November 2009, the tech giant paid $2.7 billion for routing and digital security stock 3com. Then in September 2010, Hewlett-Packard engaged in a spitting match with Dell (NASDAQ:DELL) to buy out data storage and cloud computing stock 3Par — with HP paying $2.35 billion for its “winning” bid of $33 a share, over 83% higher than Dell’s opening bid of $18 a share.

Now we have news that the company is buying British software stock Autonomy (LSS:UK:AU) (OTN:AUTNF) (OTN:AUTNY) for $10 billion.

We’ve already had HP essentially admit the Palm move was a disaster. But even if we take a huge leap of faith and assume those other moves pay off, HP is building its future profits on the work of other companies and the efficiencies it can gain from streamlining operations to maximize margins and profits.

That’s fine if you’re a CEO or executive at the top of the food chain. Not so good if you’re part of the 25,000 workers trimmed in the wake of the 2008 acquisition of Electronic Data Systems for $13.6 billion. Or the 9,000 HP employees let go in 2010, or the thousands of folks who will undoubtedly be terminated as this tech giant “consolidates” operations in the years ahead due to these bloated buyout deals.

Read about the top 5 ETFs to buy now on InvestorPlace.com.

God forbid Hewlett-Packard should grow through innovation and critical thinking — or at the very least, to simply do what it has always done in a compelling way that will connect with more consumers and businesses. That would require some leadership and some true entrepreneurial spirit.

Bloated and getting fatter So in under two years, the company will likely burn $16 billion on four multi-billion buyouts that cover consumer tech, data storage, networking and enterprise/search software.

Undoubtedly, board members will argue that Hewlett-Packard is trying to diversify its operations so it can offer a wide array of services with synergy, winning both an economy of scale and the ability to easily package related products to get the most bang for their buck.

Of course, those folks should probably stop justifying their behavior and listen to companies like Cisco (NASDAQ:CSCO) . I’ll let CEO John Chambers do the talking:

“When you’re growing, let’s just say for purposes of discussion, in the high teens, you can afford to bet in many areas,” the Cisco exec said in April. “When you’re growing in a lower number — just for purposes of discussion, let’s cut that number in half — you can’t afford many of the areas. So we’re going to cut back on the number of priorities, get very focused on our top five [and] grow it through.”

There’s nothing new about good corporations getting a little too fat and unfocused. Heck, even Wall Street darling Apple (NASDAQ:AAPL) had its moment of corporate disarray. The iconic tech company was on the verge irrelevancy in 1997 before it called Steve Jobs back to the corner office. But as you can watch on YouTube if you search for the 1997 MacWorld clip, Steve Jobs makes a rather simple but prescient statement: “Apple’s not as relevant as it used to be everywhere, but in some incredibly important market segments, it’s extraordinarily relevant.”

In short, Steve Jobs and Howard Schultz didn’t reinvent the wheel. They simply knocked off the other doo-dads and flashy lights that had stopped the wheel from rolling smoothly.

HP hasn’t gotten that memo. Instead, it continues to spend increasing amounts of money for the next big thing — not realizing that too many big things will actually cave the roof in.

No leadership Perhaps most damning is that HP is an asylum run by the inmates, with varying degrees of delusion and plain craziness across some of its biggest moves lately year.

The company announced a $10 billion buyback in 2010, and executed over $4 billion of that plan. Just weeks ago it announced plans to buy back another $10 billion in shares. Yes, HP had $12 billion in cash as of this spring… but where is that money coming from in light of this $10 billion buyout deal unveiled this week? Was the buyback plan just a PR move to cheer up investors, or did the company honestly have no idea it would be burning $10 billion in this recent buyout of Autonomy? Read why HP’s repurchase is one of 5 bogus buybacks at big-name stocks on InvestorPlace.com.

In reporting earnings Thursday, Hewlett-Packard lowered its revenue forecast for the year, which hurt the stock. But more disturbing was the sideshow that surrounded these announcements. After rumors surfaced that HP was considering spinning off its PC business, the company confirmed talks with a surprise press release — that just so happened to drop the bomb about killing its its webOS mobile business on top of disclosing earnings about a half hour before its scheduled time to report numbers.

Who the heck is running this operation?

That question looms large, as the company continues to struggle to find its way. Carly Fiorina was forced to resign as chief executive officer and chairwoman in 2005 following “differences [with the board of directors] over how to execute HP’s strategy,” according to a corporate press release. Funny to think they had one, given the last few years.

Then in 2010, CEO Mark Hurd resigned amid controversy over sexual harassment claims and shenanigans over expenses. It’s one failure in leadership after another.

This leadership vacuum is perhaps the most disturbing things for shareholders. Because until HP gets some adult supervision, it will continue to make stupid and lazy business moves — and share prices will continue to suffer.

marketwatch.com



To: Glenn Petersen who wrote (2761)10/19/2011 10:14:26 AM
From: richardred  Read Replies (1) | Respond to of 7242
 
Abbott Labs plans to split into 2 companiesAbbott Laboratories splits in 2; branded drug business to become separate company


On Wednesday October 19, 2011, 8:59 am EDT
NORTH CHICAGO, Ill. (AP) -- Abbott Laboratories plans to spin off its branded drug business and become two separate companies, the drug and medical device maker said Wednesday.

The split-up marks a dramatic change in strategy for the 123-year old company, which has long been noted for its diversified mix of medical products. As many pure pharmaceutical companies weathered losses as the patents on their blockbuster drugs expired, Abbott has continued to post double-digit earnings growth quarter after quarter, performance that many analysts credited to the company's structure.

But Wednesday's announcement indicates Abbott's management increasingly views the company as two separate businesses.

"It makes sense for stockholders because it's a company with two very different risk profiles and investment propositions: high-risk drug discovery and lower-risk generics and nutritional products," said Erik Gordon, a professor and analyst at the University of Michigan's business school. "Investors will be able to pick the one they like or, if they like the old Abbott, keep both."

Abbott, based in North Chicago, Ill., also reported a 66 percent decline in third-quarter net income as it set aside $1.5 billion for legal reserve related to an investigation into its marketing of the drug Depakote.

The new spinoff will sell Abbott's branded pharmaceuticals, including the blockbuster arthritis and immune-disorder drug Humira and the cholesterol drug Niapan. The business, which has not yet been named, will be led by Abbott's Richard Gonzalez who currently heads the company's pharmaceutical business.

The new drug company would have annual revenue of about $18 billion, Abbott said, based on 2011 estimates.

Abbott CEO Miles White will continue to lead the rest of the medical products company, which sells generics drugs, medical implants, diagnostic tests drugs and baby formula. This company will retain the Abbott name and would have annual revenue of about $22 billion.

The company said the split would allow investors to value the companies on their distinct characteristics. Shares of the new company will be distributed to Abbott shareholders in a tax-free transaction, Abbott said.

Abbott is the latest in a series of companies to announce such split-ups in the past year, including Kraft Foods Inc., the former Fortune Brands Inc. and Sara Lee Corp.

Also Wednesday, Abbott reported net income of $303 million, or 19 cents per share, down from $891 million, or 57 cents per share, in the same quarter last year.

Excluding a big charge to set aside a $1.5 billion pretax legal reserve related to the Depakote investigation, earnings were $1.18 per share, which beat analyst expectations by a penny.

Revenue rose 13.2 percent to $9.82 billion. Analysts expected $9.63 billion.

Shares of Abbott rose $5.07, or 9.7 percent, to $57.51 in premarket trading.

Abbott has been one of the pharmaceutical industry's rare success stories in recent years, largely thanks to double-digit growth of anti-inflammatory drug Humira, which posted sales of $6.5 billion last year. And while the injectable biotech drug continued to deliver double-digit growth last year, Abbott has been mostly unsuccessful in efforts to find new therapies to replace the drug.

Early this year the company withdrew the application for a next-generation psoriasis drug after the FDA indicated additional work would be needed to win approval. Humira, which treats rheumatoid arthritis and other inflammatory disease, is scheduled to lose patent protection in 2016.

In May, Abbott's best-selling cholesterol-lowering drugs were hit by back-to-back negative reviews by the federal government.

Federal scientists halted a study of Abbott's drug Niaspan, a prescription form of niacin, after preliminary results showed the pill failed to prevent heart attacks or strokes. Niacin is a form of vitamin B that boosts good cholesterol, which has been shown to fight artery buildup.

Also in May, a panel of health advisers said another Abbott drug, Trilipix, should be re-labeled to indicate that it failed to lower heart attacks in a study of diabetics. Trilipix is a fibrate, a drug that lowers blood fats called triglycerides while boosting "good cholesterol."

Sales of those drugs are expected to decline in coming quarters.

finance.yahoo.com



To: Glenn Petersen who wrote (2761)10/25/2011 1:00:13 AM
From: richardred  Read Replies (2) | Respond to of 7242
 
Jim Beam Inviting Biggest Liquor Takeover Since 2005: Real M&ABy Devin Banerjee and Duane D. Stanford - Oct 24, 2011 4:37 PM ET Mon Oct 24 20:37:57 GMT 2011

Jim Beam Inviting $11B Liquor Takeover

Tim Boyle/Bloomberg


With bourbon sales outpacing vodka in the U.S. as drinking at home increases, Beam’s command of a third of the domestic market with Jim Beam and Maker’s Mark may lure Pernod, Europe’s second-biggest distiller, or Diageo, the world’s largest spirits company.




With bourbon sales outpacing vodka in the U.S. as drinking at home increases, Beam’s command of a third of the domestic market with Jim Beam and Maker’s Mark may lure Pernod, Europe’s second-biggest distiller, or Diageo, the world’s largest spirits company. Photographer: Tim Boyle/Bloomberg



Enlarge image
Jim Beam Inviting Biggest Liquor Takeover Since 2005

John Sommers II/Bloomberg


Sales of the Jim Beam brand rose almost 8 percent in the 52 weeks ended Sept. 4, compared with a 4 percent increase for the category, according to SymphonyIRI Group, a Chicago-based market researcher.




Sales of the Jim Beam brand rose almost 8 percent in the 52 weeks ended Sept. 4, compared with a 4 percent increase for the category, according to SymphonyIRI Group, a Chicago-based market researcher. Photographer: John Sommers II/Bloomberg




Jim Beam bourbon and Skinnygirl cocktails may be enough to persuade Pernod-Ricard SA (RI) and Diageo Plc (DGE) to attempt the biggest spirits acquisition in six years.

Beam Inc., the liquor company formed in the breakup of Fortune Brands Inc. this year, would be worth about $59 a share in a takeover, said Goldman Sachs Group Inc. That would value the Deerfield, Illinois-based owner of Courvoisier cognac and Cruzan rum at $10.8 billion including net debt, making it the largest deal in the liquor industry since 2005, according to data compiled by Bloomberg.

With bourbon sales outpacing vodka in the U.S. as drinking at home increases, Beam’s command of a third of the domestic market with Jim Beam and Maker’s Mark may lure Pernod, Europe’s second-biggest distiller, or Diageo, the world’s largest spirits company, said Davenport & Co. and Goldman Sachs. While Pernod’s $14.2 billion in debt and Diageo’s distribution of tequila and cognac brands may be hurdles to a takeover, according to GFI Group Inc., Beam is an appealing entry into the bourbon market because it isn’t family controlled like Jack Daniel’s owner Brown-Forman Corp. (BF/A), said Liberum Capital Ltd.

“Beam’s bourbon play is attractive for the potential buyers,” Alfredo Scialabba, a special situations analyst at GFI Group in New York, said in a telephone interview. “They have a very strong position in the U.S., which is the most profitable market, so it would be a very nice addition to one of the other global players.”

Stephanie Schroeder, a spokeswoman for Paris-based Pernod, declined to comment on whether the company is interested in acquiring Beam.

Alcohol, Golf Balls “We will continue to look at opportunities for acquisitions where we see a chance to strengthen our company,” said Stephen Doherty, a spokesman for London-based Diageo. “Targets we pursue will be those which make strong strategic sense for our business and where the valuation is sensible.”

Beam’s shares rose as much as 1.9 percent before ending today’s trading in New York up 0.5 percent at $49.41.

Fortune Brands, an assemblage of alcohol, home and golf products, announced in December that it would split in three to focus on liquor after its largest investor, William Ackman, sought to dismantle the company to boost shareholder value. The Titleist golf unit was sold this year, and Beam and Fortune Brands Home & Security Inc. began trading independently after the Oct. 4 separation.

‘Prosperous Future’ “The new Beam is off to a great start, and we’re primed to accelerate profitable long-term growth,” said Clarkson Hine, a spokesman for Beam. “With the powerful combination of our brands, strategy, innovation engine and financial flexibility, we see a bright and prosperous future as a leading player in the dynamic spirits industry.”

He said there are many rumors in the industry that never come true and declined to comment on whether Diageo or Pernod have approached Beam.

Beam generates more than 30 percent of its sales from bourbon, primarily Jim Beam and Maker’s Mark, Judy Hong, a New York-based analyst at Goldman Sachs, wrote in an Oct. 4 report. Beam’s bourbon brands account for about a third of the total volume of bourbon sold in the U.S., Hong estimated. Bourbon is a type of whiskey that can only be produced in the U.S., must be aged in new, charred white oak barrels and made of a grain mix of at least 51 percent corn.

‘Great Business’ Earlier this year, the company bought Skinnygirl cocktails, created by Bethenny Frankel of reality TV show “The Real Housewives of New York City.” The brand caters to women with 100 calories per serving.

“We think it’s a great business and it’s a great collection,” Ackman said of Beam in a phone interview last week. “We love the business.” He declined to comment on the potential for a sale. Ackman’s Pershing Square Capital Management LP was the company’s largest investor with 13.5 percent of the shares as of Aug. 9 before the split, data compiled by Bloomberg show.

Jim Beam is the third-largest whiskey brand in the U.S. behind Brown-Forman’s Jack Daniel’s and Diageo’s Crown Royal. Sales of the Jim Beam brand rose almost 8 percent in the 52 weeks ended Sept. 4, compared with a 4 percent increase for the category, according to SymphonyIRI Group, a Chicago-based market researcher. Crown Royal grew 5 percent while Jack Daniel’s declined slightly in the same period.

Bourbon, Vodka “It’s a very valuable bourbon franchise, in particular, and a global bourbon platform,” Ann Gurkin, a Richmond, Virginia-based analyst at Davenport, said in a phone interview. “There is big potential for growth.”

Sales of bourbon have outpaced vodka in the U.S. this year, according to Nielsen Holdings NV, a New York-based research company. Growth is being driven, in part, by new flavored bourbon drinks, such as the black cherry-flavored Jim Beam Red Stag that was introduced in 2009.

While alcohol consumption has declined at restaurants and bars, drinking at home has risen steadily in the U.S. after the longest recession since the Great Depression ended in June 2009. The Real Personal Consumption Expenditures of Alcoholic Beverages for Off Premises Index has gained 13 percent since then and reached a record in August, the last month for which figures were available, according to data compiled by Bloomberg.

Jack Daniel’s Beam is also an attractive acquisition target because it’s one of the only spirits companies not controlled by a family, Pablo Zuanic, a New York-based analyst at Liberum Capital, said in a phone interview. Jack Daniel’s Tennessee Whiskey and Early Times 354 Kentucky Bourbon Whiskey are made by family-owned Brown-Forman.

“There’s not a lot of hurdles if an acquirer wants to pursue an acquisition at Beam,” Goldman Sachs’ Hong said in a phone interview. “There’s a scarcity of assets out there. A lot of the multinational companies like Diageo or Pernod really don’t have a major presence in the global bourbon category.”

Beam is worth about $59 a share in a takeover by valuing the company’s equity and debt at about 14.3 times estimated earnings before interest, taxes, depreciation and amortization of $757 million in the next 12 months, according to Hong. That multiple is based on past deals in the spirits industry, said Hong, who estimates there’s a 30 percent to 50 percent chance of Beam being acquired.

Allied Domecq At $10.8 billion including net debt, a takeover of Beam would be the biggest deal in the spirits industry since Pernod agreed to buy Allied Domecq Plc in 2005 for 9.32 billion pounds ($17.8 billion), data compiled by Bloomberg show.

Since it was separated earlier this month, Beam had already gained 17 percent to $49.17 as of last week, giving it a market value of about $7.6 billion. That means a takeover at $59 a share would only represent a 20 percent premium.

Applying the average premium of 31 percent in spirits takeovers greater than $1 billion, Beam would be worth about $64.41 a share, or $9.95 billion plus about $1.7 billion in net debt, data compiled by Bloomberg show.

“There’s a lot of excitement and speculation around this stock,” said GFI Group’s Scialabba. “But, of course, it’s expensive right now.”

Beam may instead be a buyer. Chief Executive Officer Matt Shattock said last month the standalone liquor company is prepared to make large acquisitions if the right opportunity arises. He declined to identify potential targets.

‘Won’t Feel Constrained’ “We won’t feel constrained in terms of the scale,” Shattock said in a Sept. 14 phone interview. “We have a strong and very flexible capital structure and that gives us the opportunity to contemplate various types of transactions.”

Still, Pernod, which makes Chivas Regal whiskey and Absolut vodka, may be interested in acquiring Beam, according to Goldman Sachs’s Hong and Davenport’s Gurkin. Beam would give the distiller, which currently has no U.S. bourbon brand, a 31 percent share of the American bourbon market and carry Pernod into the Canadian market, according to Liberum Capital’s Zuanic.

“If Pernod were to buy Beam, in the U.S. it would be almost as big as Diageo,” Zuanic said. “It’s more strategic to Pernod.”

Pernod is seeking to cut its borrowings to about four times adjusted Ebitda by June 2012, from 4.4 times as of June 30. Pernod, which was boosted to investment grade by Moody’s Investors Service last month, was able to raise $1.5 billion from its biggest dollar bond sale last week with the lowest coupon it’s ever paid for 10-year debt. The distiller had total debt of almost 9.8 billion euros ($14.2 billion) as of June 30, data compiled by Bloomberg show.

‘Many Toys’ There will be no “transformational acquisitions from our side in this and the next fiscal year,” Pernod CEO Pierre Pringuet said last week in a phone interview.

“You can be like a child looking at the shop windows, saying ‘there are many toys I’d like to buy,’” Pringuet said. “But we have one focus today, to continue to deleverage the group.”

Diageo “continues to be the frontrunner in terms of chatter about a Beam takeout,” Vivien Azer, an analyst at Citigroup Inc. in New York, said in a phone interview. Diageo, which is facing slower sales growth in Europe and the U.S., may want to buy Beam to gain share in the American bourbon market. Acquiring Beam would boost Diageo’s share of the U.S. bourbon market to 44 percent from 13 percent, according to Liberum Capital’s Zuanic.

‘Defensive Move’ “It’s strategic for Diageo because it would put them in a very, very strong position in the U.S.,” Zuanic said. “It would also be a defensive move, to some extent, against Pernod.”

The seller of Johnnie Walker Scotch whisky, Smirnoff vodka and Guinness beer could also expand Beam’s bourbon sales in Europe and Asia, where Brown-Forman has done relatively well selling its Jack Daniel’s Tennessee whiskey, Zuanic said.

Diageo would need to resolve conflicting distribution agreements, including with LVMH Moet Hennessy Louis Vuitton SA (MC), said GFI Group’s Scialabba. Diageo already has distribution deals with Jose Cuervo tequila and LVMH’s alcohol division for Hennessy cognac. Beam makes Courvoisier cognac and Sauza tequila.

United Spirits Ltd. (UNSP) of Bangalore, India, has said it’s interested in buying Beam’s Teacher’s Scotch whisky, the best- selling Scotch whisky in India, the Wall Street Journal reported Sept. 29, citing comments by United Spirits Managing Director Ashok Capoor. Capoor told the Journal that the companies hadn’t approached each other. The company didn’t respond to an e-mail sent to its media relations department requesting comment.

“The spirits market itself is relatively fragmented, so the consolidation is a trend that we think will continue,” said Goldman Sachs’ Hong. “Beam, with their Jim Beam brand, has the strategic appeal of being one of the few global bourbon brands.”

bloomberg.com



To: Glenn Petersen who wrote (2761)10/9/2012 6:14:35 PM
From: richardred  Read Replies (1) | Respond to of 7242
 
Alcoa could be next
mobile.bloomberg.com



To: Glenn Petersen who wrote (2761)10/8/2014 9:34:24 AM
From: richardred  Read Replies (1) | Respond to of 7242
 
Seems to be a resurgence of the Starburst this year also.



To: Glenn Petersen who wrote (2761)11/5/2015 10:43:31 AM
From: richardred  Respond to of 7242
 
Glen it seems time for a Starburst of VRX? In a different way . It's starting to remind me TYCO which ended up selling off parts of the company.

P.S. Maybe Bausch & Lomb will trade as a separate company again one day.?